X4 Pharmaceuticals raises $135mln in public offering.
ByAinvest
Friday, Oct 24, 2025 12:40 am ET1min read
XFOR--
X4 Pharmaceuticals has priced a public offering of 45.86 million shares of common stock at $2.90 per share, raising approximately $135 million. The offering also includes pre-funded warrants to purchase up to 700,000 shares. The deal is expected to close on October 27, 2025, subject to customary conditions. The funds raised will be used for general corporate purposes.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet